Onderneming JHL Biotech, Inc.
Aandelen
6540
KYG7863U1076
Farmaceutische producten
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 76 | 12-06-12 | |
Ellis Chu
DFI | Director of Finance/CFO | - | 01-05-18 |
Cui WeiDong
CTO | Chief Tech/Sci/R&D Officer | - | - |
Rong Chen
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-18 |
DJ Lin
LAW | General Counsel | - | 31-03-17 |
Jill Liu
AUD | Comptroller/Controller/Auditor | - | 01-01-15 |
Peter Pang
LAW | General Counsel | - | 01-11-14 |
Nick Kotlarski
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | - | |
Max Chan
AUD | Comptroller/Controller/Auditor | 56 | 20-10-15 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Zuie Chin Huang
CHM | Chairman | 58 | 17-12-12 |
Bryant Fong
BRD | Director/Board Member | 51 | 17-12-12 |
Yi Hsiung Chen
BRD | Director/Board Member | - | 14-05-15 |
Ying Du
BRD | Director/Board Member | 59 | 17-12-12 |
Chief Executive Officer | 76 | 12-06-12 | |
Rose Lin
FOU | Founder | - | 12-06-12 |
Jun Wu
BRD | Director/Board Member | - | 14-05-15 |
Chia Lin Wang
BRD | Director/Board Member | - | 14-05-15 |
Fang Hsi Teng
BRD | Director/Board Member | - | 14-05-15 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 220 403 607 | 220 403 607 ( 100,00 %) | 0 | 100,00 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-3,15% | 89,69 mld. | |
+2,50% | 41,34 mld. | |
-12,01% | 33,72 mld. | |
+62,74% | 26,11 mld. | |
-19,79% | 14,63 mld. | |
-8,58% | 12,84 mld. | |
-12,34% | 11,66 mld. | |
-43,92% | 11,52 mld. | |
+4,27% | 8,92 mld. |